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Interdependence between Heme Oxygenase-1
Induction and Estrogen-Receptor-b Signaling
Mediates Photoimmune Protection by UVA Radiation
in Mice
Vivienne E. Reeve1, Munif Allanson1, Jun-Lae Cho1, Sondur J. Arun1 and Diane Domanski1
Previous studies have found that signaling by the estrogen receptor-b (Er-b) attenuated solar-simulated UV
radiation (SSUV)-induced immunosuppression. This study seeks evidence for a common mechanism for this
immunoprotection for both Er-b signaling and irradiation with the UVA waveband. In Skh:hr-1 hairless mice, the
immunoprotection afforded by UVA exposure against subsequent UVB or cis-urocanic acid suppression of
contact hypersensitivity (CHS) was abrogated by treatment with the antiestrogen, ICI 182,780. Furthermore, in
normal C57BL mice, UVA enrichment of UVA/UVB sources provided protection against UVB-suppressed CHS
and upregulated epidermal IL-10 expression, but this protection was inhibited in Er-b/ mice. These
observations indicated that the immunoprotective response to UVA was dependent on Er-b signaling. As earlier
studies have established that UVA photoimmune protection depends on the induction of the stress enzyme,
heme oxygenase (HO)-1, its activity was examined relative to Er-b. Immunoprotection against SSUV by 17-b-
estradiol was prevented by inhibiting HO enzyme activity; immunoprotection against cis-urocanic acid by
carbon monoxide (HO product) was prevented by ICI 182,780. In addition, the HO-1 gene was unresponsive to
UVA induction in Er-b/ mice. Therefore, HO-1 inducibility and Er-b signaling are interdependent requisite
responses to the UVA waveband for its immunoprotective action against UVB exposure.
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INTRODUCTION
Recent studies in mice have revealed an important role for
estrogen receptor (Er) signaling in attenuating the immuno-
suppressive effect of UV radiation. In the Skh:hr-1 hairless
mouse, a topical application of either the phytoestrogenic
isoflavone equol or 17-b-estradiol was shown to inhibit dose-
dependently the immunosuppressive effect of solar-simulated
UV radiation (SSUV) or its cutaneous immunosuppressive
photoproduct, cis-urocanic acid, when measured by the
contact hypersensitivity (CHS) response (Widyarini et al.,
2006). This immunoprotection could be antagonized by a
topical application of the Er antagonist, ICI 182,780, implying
that Er signaling provides an endogenous regulatory pathway
to protect against photoimmune suppression. Further studies
identified the non-classical receptor, Er-b, in the skin as the
mediator of this effect, because the Skh:hr-1 skin was
deficient in the classical receptor, Er-a (Cho et al., 2008). In
mice with a null mutation for Er-b (Er-b/), immune
suppression by SSUV was shown to be exacerbated
compared with that in the normal C57BL/6 mouse.
A possible UV waveband dependence of the Er-b-
mediated immunoprotection was suggested, as waveband
interactions between UVA (320–400nm) and UVB
(290–320nm) are recognized as affecting the photoimmune
suppressive response, and these wavebands have been
associated with opposing alterations of critical cytokines in
the skin of mice (Shen et al., 1999; Reeve et al., 2006). The
hallmark of the epidermal cytokine disarray characterizing
photoimmune suppression is the overexpression of Th2-
associated IL-10 (Ullrich, 2005) and a deficiency of Th1-
associated IL-12 and IFN-g, attributable largely to the effects
of UVB. In contrast, exposure to the UVA waveband
promotes the expression of IL-12 and IFN-g, and protects
these immune potentiating cytokines from depletion by
subsequent or concurrent UVB irradiation. Importantly,
UVA has a dose-dependent capacity to reverse the
UVB-induced suppression of CHS in mice (Reeve et al.,
2006). Therefore, it was consistent with the extreme
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immunosuppressed response to SSUV in the Er-b/ mouse,
that when irradiated with the UVA and UVB components of
SSUV separately, the UVB-induced epidermal expression of
IL-10 was more greatly enhanced than that in the C57BL/6
mouse, and the UVA upregulation of IL-12 and IFN-g was
decreased (Cho et al., 2008). These results suggested that Er-b
signaling might be involved in the UVA-dependent immu-
noprotection against UVB immunosuppression, which has
been documented in normal haired and hairless mice, the
marsupial Monodelphis domestica (Reeve et al., 1998, 1999,
2006; Ley et al., 2000), and in humans (Sjovall and
Christensen, 1986; Skov et al., 2000).
However, in addition to the normalizing effect on
cutaneous cytokines, photoimmune protection by UVA
radiation is also dependent on UVA induction in skin cells
of the stress enzyme, heme oxygenase-1 (HO-1). This redox-
regulated enzyme catalyzes the degradation of heme to
release biliverdin and the immunologically active product,
carbon monoxide (CO) (Reeve and Tyrrell, 1999; Allanson
and Reeve, 2004). Interestingly, the Er is known to have
various antioxidant response elements, indicating that it is
redox sensitive. Er signaling has been reported to induce
several antioxidant enzymes such as quinone reductase,
glutathione-S-transferase, and g-glutamylcysteine synthase
(Montano and Katzenellenbogen, 1997; Montano et al.,
2004), suggesting a broad protective role against oxidative
stress. HO-1 induction has also been reported to be estrogen
or Er-b dependent in extracutaneous stressed tissues (Naka-
mura et al., 2006; Yu et al., 2006), leading to the possibility
that the immune-modulating properties of Er-b signaling in
the skin may be associated not only with cytokine protection
but also with oxidative stress and inducible HO-1 activity.
Therefore, this study uses both the Er-b/ mouse in com-
parison with the normal C57BL/6 mouse, and the Skh:hr-1
hairless mouse with or without pharmacological Er blockade,
to reveal the activity of Er-b in the immunomodulating
actions of exposure to UVA and UVB radiation, whether
administered to mice separately, or combined sequentially,
or concurrently to simulate solar UV exposure in humans.
The Er-b dependence of the effect of UVA/UVB interactions
on cutaneous IL-10 expression will be described and
correlated with the resultant immune function, measured as
the CHS response. This study also seeks evidence of a link
between Er-dependent photoimmune protection and induci-
ble HO-1 activity in the skin.
RESULTS
UVA immune protection against UVB is abrogated by
pharmacological Er-blockade by ICI 182,780 (Skh:hr-1 hairless
mice)
The normal CHS reaction of the hairless mouse to oxazolone
is shown as an approximate doubling of the average ear
thickness by 30.7mm 0.01. Exposure of the mice to
400 kJ/m2 of UVA alone did not significantly affect the CHS
response to oxazolone, nor did the topical application of
the antiestrogen, ICI 182,780, alone or combined with UVA
irradiation (Figure 1). As expected, irradiation with a single
dose of 3 minimal edematous dose (MedD) of UVB was
strongly immunosuppressive, reducing the CHS response by
58% to an average ear swelling of 13.0mm 0.01. However,
if the UVB irradiation followed an earlier exposure to
400 kJ/m2 of UVA, the average ear swelling was maintained
at 20.2mm 0.01, and the degree of suppression of CHS was
highly significantly (Po0.001) reduced from 58 to 34%,
although a significant (Po0.001) degree of immunosuppres-
sion remained, compared with normal (NIL).
In contrast, the blockade of the Er with ICI 182,780,
although having no significant effect on the degree of UVB
suppression of CHS (average ear swelling of 11.6mm0.01;
62% suppression), totally abrogated the UVA protection against
this suppression (Po0.001), and the average ear swelling
remained at 10.3mm 0.01, or 66% suppression of CHS. Thus,
the protection by UVA against a subsequent UVB-induced
suppression of CHS was shown to be dependent on the Er.
UVA immune protection against cis-UCA is abrogated by
pharmacological Er-blockade by ICI 182,780 (Skh:hr-1 hairless
mice)
Hairless mice treated topically with the immunosuppressive
UV photoproduct, cis-UCA, developed a strong suppression
of the CHS reaction similar to the effect of UVB irradiation
(Figure 2), without the overt inflammation resulting from UVB
irradiation. Average ear swelling was reduced from 37.1 to
20.3mm0.01, a suppression of 45%. The earlier irradiation
with 400 kJ/m2 of UVA, however, largely (Po0.001) pro-
tected against the cis-UCA-induced immunosuppression, and
the average ear swelling remained at 30.1mm 0.01, or only
19% suppression of CHS, indicating the remaining of a small
but significant (Po0.001) degree of immunosuppression
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Figure 1. Estrogen receptor blockade prevents UVA protection against UVB-
induced immunosuppression in the Skh:hr-1 hairless mouse. Groups of five
mice were treated topically twice weekly on the dorsum with ICI 182,780 or
with vehicle only, and were irradiated (or not) on the dorsum with a single
dose of either 3 minimal edematous dose of UVB (3.78 kJ/m2) or 400 kJ/m2
UVA, or UVA followed immediately by UVB. Contact hypersensitivity was
induced on the unirradiated abdomen with oxazolone, elicited on the ears,
and expressed as the peak group average ear swelling±SEM. The negative
control treatment was elicitation without earlier oxazolone sensitization and
was nonsignificant. Matching symbols indicate significantly differing
responses.
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compared with normal (NIL). Er blockade with topical ICI
182,780 did not significantly alter the CHS reaction, alone or
when combined with UVA irradiation, nor did it significantly
affect the cis-UCA-induced immunosuppression (40% sup-
pression). Topical application of ICI 182,780 prevented UVA
immunoprotection against cis-UCA, and even further sig-
nificantly (Po0.001) reduced the average ear swelling from
22.4 to 15.4mm0.01, or a 58% suppression of CHS. This
degree of immunosuppression was, however, not signifi-
cantly greater than the immunosuppression resulting from cis-
urocanic acid alone. Thus, UVA-induced immunoprotection
against the suppression of CHS by either UVB radiation or its
major immunosuppressive mediator, cis-UCA, applied sub-
sequently, was shown to require signaling by the Er.
SSUV-induced immunosuppression is exacerbated, and
immunoprotection by UVA enrichment of SSUV is inhibited in
Er-b/ mice
The constitutive CHS reaction in the Er-b/ mice was
slightly (by 12%) but significantly (Po0.01) suppressed
compared with that in the C57BL mice, as has been
previously reported (Cho et al., 2008), and may result from
the constitutive expression of epidermal IL-10 in this mouse,
as described below. However, the responses to UV irradia-
tion of the two mouse strains differed markedly. In the C57BL
mouse, exposure to a single dose of 3 MEdD of SSUV
radiation reduced the average ear swelling from 33.7 to
23.0mm0.01, a reduction of CHS by 32% (Figure 3). By
comparison, in the Er-b/ mouse, this degree of suppres-
sion was significantly exacerbated compared with that in the
unirradiated Er-b/ mice (Po0.001), and the average ear
swelling was reduced to 16.6mm0.01, a suppression of
CHS of 46%, consistent with the previous report (Cho et al.,
2008).
The UVA/UVB ratio in the SSUV source was 17.8. As the
results in Figures 1 and 2 indicate an immunoprotective
association between the UVA waveband and Er signaling,
two additional UV sources were administered to these mice,
providing the same UVB content but with an enrichment of
the UVA component. In the normal C57BL mouse, the
suppressed CHS reaction by SSUV was progressively restored
(Figure 3) as the UVA/UVB ratio was increased from 17.8 to
29.0 (Po0.01), and again to 44.4 (Po0.001). At the highest
UVA/UVB ratio (44.4), suppression of CHS was totally
abrogated. In contrast, exposure of the Er-b/ mouse to
an enriched UVA/UVB ratio of 29.0 did not display any
significant attenuation of the degree of immunosuppression,
whereas exposure to an enriched UVA/UVB ratio of 44.4 did
afford significant protection, but the CHS response remained
significantly less (Po0.001) than the non-irradiated response.
Thus, the immunoprotective interaction of UVA with UVB,
when these wavebands are administered concurrently, was
shown to be reduced in the absence of signaling by the Er-b.
Lack of UVA immunoprotection in Er-b/ mice is correlated
with increased epidermal IL-10 expression
The expression of immunohistochemically detected IL-10 in
the C57BL epidermis was absent in unirradiated skin,
whereas IL-10 was clearly present in the unirradiated Er-
b/ epidermis (Figure 4a). At 5 days after exposure to 3
MEdD of SSUV (UVA/UVB ratio 17.8), unit IL-10 expression
appeared in the C57BL epidermis, but there was a stronger
staining in the Er-b/ skin. Furthermore, as the UVA/UVB
ratio of the radiation was increased to 29.0 and 44.4, the
IL-10 expression in the C57BL epidermis became succes-
sively weaker, but a stronger IL-10 expression remained in
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Figure 2. Estrogen receptor blockade prevents UVA protection against cis-
urocanic acid-induced immunosuppression in the Skh:hr-1 hairless mouse.
Groups of five mice were treated topically twice weekly on the dorsum with
ICI 182,780 or with vehicle only, and were irradiated (or not) on the dorsum
with 400 kJ/m2 UVA, followed by 0.2mg cis-urocanic acid (cis-UCA)-
containing lotion or vehicle applied to the dorsum thrice in the next 24 hours.
Contact hypersensitivity was induced on the unirradiated abdomen with
oxazolone, elicited on the ears, and expressed as the peak group average ear
swelling±SEM. Matching symbols indicate significantly differing responses.
**
* ###
* ##
##
*** #
***
###
** #
32% I/S
20%
26%
42%
46%
Er-β–/–
C57BL
*  **  *** P < 0.01
# ## ### P < 0.001
NIL
UVA/UVB 17.8
UVA/UVB 29.0
UVA/UVB 44.4
–ve CON
Average ear swelling  (mm × 0.01)
0 10 20 30 40
Figure 3. Immunoprotection by increased UVA/UVB ratio is attenuated in
the estrogen receptor (Er)-b/ mouse. Groups of five shaved C57BL or
Er-b/ mice were irradiated with 1 MEdD of SSUV, or with the same UVB
dose combined with an increased UVA component (UVA/UVB 29.0 or 44.4),
on 3 consecutive days. Contact hypersensitivity was induced on the
unirradiated abdomen with oxazolone, elicited on the ears, and expressed as
the peak group average ear swelling±SEM. The negative control treatment
was elicitation without earlier oxazolone sensitization. Matching symbols
indicate significantly differing responses.
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the Er-b/ epidermis. Semiquantitation by image analysis
supports these observations (Figure 4b). Thus, the lack of
immunoprotection by UVA enrichment in the Er-b/mouse
was matched by the retention of a strong IL-10 expression,
compared with the C57BL mouse in which UVA enrichment
provided both reduced immunosuppression and reduced
IL-10 expression.
Inhibition of HO activity with tin protoporphyrin-IX inhibits
17-b-estradiol-induced photoimmune protection (Skh:hr-1 mice)
A subcutaneous injection of the specific substrate antagonist
of HO, tin protoporphyrin-IX (SnPP), is known to inhibit HO
enzyme activity in the mouse skin, and has been found to
prevent the photoimmune protective properties of UVA
radiation by its inhibition of the inducible isoform, HO-1,
but not the activity of the constitutive isoform, HO-2 (Reeve
and Tyrrell, 1999). Consistent with these previous results,
SnPP alone had no effect on the CHS response in the hairless
mouse (Figure 5), but the SSUV-suppressed CHS response
(43% suppression) was significantly (Po0.001) exacerbated
by SnPP treatment (61% suppression). In contrast, topical
application of 17-b-estradiol largely and significantly
(Po0.001) attenuated the SSUV suppression of CHS, which
was approximately halved from 43 to 21% suppression.
However, this immune protection by 17-b-estradiol was
abrogated in the SnPP-treated mice, and the CHS response
was suppressed by 49% to a similar level of suppression that
resulted from SSUV exposure alone (43%). Thus, a require-
ment for inducible HO-1 activity was revealed for the
facilitation of the estrogen-dependent immunoprotective
pathway.
Er blockade (ICI 182,780) abrogates CO-RM protection against
cis-UCA (Skh:hr-1 mice)
To support the apparent role of HO-1 in estrogen-dependent
immunoprotection, hairless mice were treated with the
immunosuppressive cutaneous photoproduct, cis-urocanic
acid, instead of with SSUV radiation, resulting in a 25%
suppression of CHS (Figure 6). Consistent with the results in
Figure 2, Er blockade did not significantly exacerbate the cis-
urocanic acid immunosuppression (27% suppression). Topi-
cal treatment of mice with the CO releasing molecule (CO-
RM), simulating the production of CO by induced HO
enzyme activity, was found to restore the CHS response (6%
suppression; not significantly different from NIL treatment).
However, the CO-RM protection was reversed when CO-RM
was combined with ICI 178,820 application. Thus, Er
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Figure 4. Inhibited UVA photoimmune protection in the estrogen receptor
(Er)-b/mouse is correlated with increased epidermal IL-10 expression. (a)
Groups of three shaved C57BL or Er-b/ mice were irradiated with a single
dose of 3 MEdD of solar-simulated UV radiation (UVA/UVB 17.8) or with the
same UVB dose combined with an increased UVA component (UVA/UVB
29.0 or 44.4). At 5 days after UV, mid-dorsal skin samples were histologically
fixed, paraffin embedded, and subjected to immunohistochemical staining for
IL-10. The UVA-enriched radiation reduced epidermal IL-10 expression
(brown staining) in C57BL mice, but enhanced the expression in Er-b/
mice. Primary anti-IL-10 antibody was omitted in the negative control. Scale
bar¼ 50 mm. (b) Image analysis semiquantitation of epidermal IL-10
immunostaining intensity±SEM.
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Figure 5. Photoimmune protection by topical 17-b-estradiol is prevented by
inhibition of heme oxygenase (HO) enzyme activity. Groups of five Skh:hr-1
mice, which had been receiving twice weekly topical 17-b-estradiol (E2) or
vehicle on the dorsum, were irradiated with a single dose of 3 MEdD of SSUV,
then injected subcutaneously with the HO inhibitor, tin protoporphyrin-IX
(SnPP). Contact hypersensitivity was induced on the unirradiated abdomen
with oxazolone, elicited on the ears, and expressed as the peak group average
ear swelling ± SEM. Matching symbols indicate significantly differing
responses.
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signaling is necessary for the immunoprotection attributable
to HO activity.
UVA does not induce HO-1 mRNA or protein in the Er-b/
mouse
The inhibition of the HO-dependent immunoprotective
pathway by Er blockade suggested that the HO-1 response
to the immunoprotective UVA waveband might be Er
dependent. A comparison of the expression of cutaneous
HO-1 showed that, although HO-1 mRNA was virtually
undetectable in C57BL skin, it was constitutively expressed in
the Er-b/mouse (Figure 7a), and at an elevated level that is
approximately half of the normally induced expression in the
C57BL skin, when measured semiquantitatively by image
analysis (Figure 7b). Furthermore, whereas UVA irradiation
induced HO-1 mRNA in the C57BL skin by 3 hours, the
abnormally elevated constitutive expression in the Er-b/
skin did not increase.
In support of this observation, the inducibility of the HO-1
protein at 72 hours after UVA was also sought by immuno-
histochemistry. Consistent with the constitutive elevation and
subsequent failure of HO-1 mRNA induction by UVA, it was
found that the HO-1 protein was likewise overexpressed in
untreated Er-b/ skin compared with that in C57BL skin,
and unlike the C57BL skin, there was no evidence of HO-1
induction by UVA irradiation (Figure 8).
It was concluded not only that the untreated Er-b/
mouse seems to be under oxidative stress but also that the
HO-1 gene was refractory to UVA induction in the absence of
Er-b activity. Thus, the inducibility of HO-1 by UVA radiation
depends on signaling by the Er-b.
DISCUSSION
In these experiments, the disabling of Er-b in either the
Er-b/ mouse or the Skh:hr-1 hairless mouse treated with
the antiestrogen, ICI 182,780, has enabled us to confirm the
importance of signaling by this receptor in providing an
endogenous mechanism for the protection of the immune
system against UVB suppression. In the absence of Er-b
signaling, the capacity of UVA exposure to protect against
subsequent UVB irradiation was strongly inhibited, and this
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Figure 6. Er blockade prevents carbon monoxide releasing molecule
(CO-RM) immunoprotection against cis-urocanic acid. Groups of five
Skh:hr-1 mice, which had been receiving twice weekly topical ICI 182,780 or
vehicle applications on the dorsum, were treated topically on the dorsum with
fresh CO-RM on 3 consecutive days, followed each day by application of
cis-urocanic acid-containing lotion after 1 hour. Contact hypersensitivity was
induced on the unirradiated abdomen with oxazolone, elicited on the ears,
and expressed as the peak group average ear swelling±SEM. Matching
symbols indicate significantly differing responses.
C57BL
0.14
0
0.07
Im
ag
e 
an
al
ys
is 
un
its
Nil
b
a
Nil UVA
Nil6 63 324 24 h
Post-UVA
HO-1
β-Actin
Er-β–/–
C57BL Er-β–/–
Figure 7. Heme oxygenase (HO)-1 mRNA expression is elevated in Er-b/
mouse skin, but is unresponsive to UVA radiation. (a) Mid-dorsal skin
samples were taken from groups of three shaved C57BL and Er-b/ mice
before and at 3, 6, and 24 hours after irradiation with 400 kJ/m2 of UVA
radiation, and analyzed by reverse-transcriptase–PCR for expression of HO-1
mRNA. (b) The positively stained bands at 3 hours after UVA were
semiquantitated by image analysis normalized for b-actin content and
expressed as arbitrary units±SEM.
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Figure 8. Heme oxygenase (HO)-1 protein expression is elevated in Er-b/
mouse skin, but is unresponsive to UVA radiation. Mid-dorsal skin samples
were snap frozen from groups of three shaved C57BL and Er-b/ mice
before and at 72 hours after irradiation with 400 kJ/m2 of UVA radiation.
Frozen sections were stained immunohistochemically for the HO-1 protein
and show positive staining in the epidermis and some dermal cells after UVA
exposure in C57BL mice, but both before and after UVA exposure in Er-b/
mice. The primary anti-HO-1 antibody was omitted for the negative control.
Scale bar¼ 50 mm.
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was shown to hold also for mice immunosuppressed with cis-
urocanic acid. The more environmentally relevant irradiation
with the two wavebands administered concurrently showed
that an enrichment of the UVA component of the radiation
source progressively reduced the degree of immunosuppres-
sion resulting from a constant UVB dose in normal mice, but
not in Er-b-deficient mice. This exacerbated susceptibility to
photoimmune suppression correlated with the greater ex-
pression of the Th2 cytokine, IL-10, in the Er-b/ epidermis,
whereas the normal C57BL mouse exhibited a progressively
reduced IL-10 expression as the UVA/UVB ratio was
increased.
Previous studies in the mouse had indicated that UVA
radiation acquired its photoimmune protective properties
through the UVA inducibility of HO-1 in the epidermis
(Reeve and Tyrrell, 1999). Therefore, the question of whether
there was an association between Er-b signaling and HO-1
activity was addressed, using the Skh:hr-1 hairless mouse
injected with the HO inhibitor, SnPP. In contrast to the
uninhibited mouse, in which a topical application of estradiol
effectively prevented the SSUV suppression of CHS, the
SnPP-injected mouse was unresponsive to topical estradiol
and remained as immunosuppressed as did mice irradiated
with SSUV alone. Furthermore, Er blockade with ICI 182,780
in mice in which the enzyme activity of HO was simulated by
treating with CO-RM totally abrogated the capacity of CO to
protect against the immune suppression induced, in this
experiment, with topical cis-urocanic acid. An important
relationship between induction of HO-1 and Er signaling for
the protection of photoimmune suppression was thus
revealed, each of these mediators having been established
as responding to the UVA waveband.
It was therefore not surprising to find also that the Er-b/
mouse did not seem to have normal HO-1 inducibility
responses; instead it exhibited an abnormally elevated
constitutive level of HO-1 mRNA and protein in the
epidermis, which remained unchanged after UVA exposure,
whereas the normal C57BL mouse showed a strong UVA
upregulation of HO-1 mRNA and protein expressions. The
abnormal overexpression of HO-1 constitutively and the
failure to elicit UVA induction of HO-1 activity have likewise
been reported in mice deficient in the Th1 cytokine, IFN-g
(Reeve and Domanski, 2003), which also remain unrespon-
sive to UVA-induced immunoprotection against cis-urocanic
acid (Reeve et al., 1999). It remains unclear why the
abundant constitutive presence of HO-1 does not provide
photoimmune protection, but suggests that it is the respon-
siveness of the HO-1 gene to stressors that is necessary for the
photoimmune protection pathway induced by UVA radia-
tion. The oxidative activation of HO-1 depends on the release
of the transcriptional repressor, Bach1, which is achieved by
its avid binding of heme and its subsequent export from the
nucleus (Alam et al., 2004). Interestingly, the heme–Bach1
complex has a strong UVA absorption peak at 371 nm (Hira
et al., 2007), suggesting a possible interference by UVA in the
capacity to regenerate active Bach1 for the cyclic inactivation
of the HO-1 gene. Furthermore, in studies of the mouse brain,
mice with a null mutation for Bach1 also had a significantly
elevated constitutive HO-1 level, but again this had no tissue
protective effects against stress (Sakoda et al., 2008),
implicating the pivotal role of the regulation of the gene
response in triggering protective pathways. Our study
indicates that this is supported or facilitated through Er-b
signaling, and further studies are needed to elucidate the
factors involved. A dependence of stress-induced HO-1
induction on Er signaling, particularly that of Er-b, has been
observed by others in the brain and intestine (Nakamura
et al., 2006; Yu et al., 2006).
It is interesting that the CHS studies described here and in
earlier reports illustrate that UVB- or cis-urocanic acid-
induced immunosuppression is not affected either by Er
blockade (Figures 1, 2 and 6) or HO inhibition (Reeve and
Tyrrell, 1999). In contrast, if mice were irradiated
with broader spectrum SSUV, which provides a UVA
component in addition to UVB, immunosuppression was
exacerbated both by Er blockade (Widyarini et al., 2006) and
SnPP (Figure 5). This is consistent with the photoimmune
regulatory role of the UVA waveband being mediated by
both the Er and HO-1 pathways, and shows that the
UVA component of the solar UV spectrum is immunoprotec-
tively responsive through HO-1 inducibility and Er-b
signaling pathways, which should provide advantageous
targets for photoimmune protection in humans. Obviously,
further human data are urgently required, as the capacity
for UVA immunoprotection in humans is highly controversial
at present. Human data may be clouded by the claimed
spectral specificities of the various radiation sources
that have been used in human studies, as recently reviewed
(Reeve and Tyrrell, 2007), or by the local or systemic effects
of immune function being measured (both are similarly
responsive to UVA immunoprotection in hairless mice;
Reeve et al., 1998), or by assays of either the induction
or elicitation phases of CHS (we have found these to be
similarly responsive to UVA in hairless mice; unpublished
observation).
The murine models that we have used were useful because
of their specific Er predominance, the Skh:hr-1 mouse being
deficient in cutaneous Er-a and the Er-b/ mouse being
deficient in Er-b. Human skin fibroblasts, however, are
reported to express both Er-a and Er-b, which are activated
by different modulators (Haczynski et al., 2002, 2004). This is
modeled in our study by the normal C57BL mouse, in which
the constitutive co-expression of both Er isoforms did not
change the immunologically advantageous responses of Er-b
to the UVA waveband, confirming the Er-b specificity of this
phenomenon. The functions of Er-b are less well documented
than those of Er-a in the tissues that have been studied, but
recent reports have suggested that Er-b may antagonize the
activity of Er-a in non-steroid target human tissues, such as
the brain (Gonzales et al., 2008; Weiser et al., 2008) or
squamous-cell carcinoma of the esophagus (Nozoe et al.,
2007), and in breast cancer (Macaluso et al., 2006; Lin et al.,
2007; Shupnik, 2007). In mouse skin, Er-b signaling was
found to inhibit the Er-a-mediated induction of the catagen
phase of the hair growth cycle (Ohnemus et al., 2005).
Further studies of the cutaneous responses may reveal a role
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for selective Er modulators in enhancing the photoimmune
protective activity of Er-b.
Photoimmune suppression is understood to be a prerequi-
site for photocarcinogenesis in mice and humans (Ullrich,
2005). Therefore, studies are underway to investigate the
potential of UVA-induced immune protection through Er-b
and HO-1 signaling to attenuate skin cancer induction in
murine models, with the possibility of being translated into
protection against the hazards of solar UV overexposure in
humans.
MATERIALS AND METHODS
Mice
Inbred female Skh:hr-1 hairless albino mice (express Er-b in the skin,
deficient in Er-a) and normal haired C57BL/6 mice (‘‘C57BL’’;
express both Er-a and Er-b), 8–12 weeks of age, were obtained from
the Veterinary Science breeding colonies. A breeding colony of the
Er-b-targeted mutation strain (B6.129P2-Esr2tm1Unc/J) provided the
Er-b/ female mice (express only Er-a), identified from their Er-
bþ / heterozygous littermates by reverse-transcriptase PCR from a
tail sample (Cho et al., 2008).
The mice were maintained in a ventilated isolator caging system
on compressed paper bedding (Fibrecycle Pty. Ltd, Mudgeeraba,
Queensland, Australia) and were fed stock rodent pellets (Gordons
Specialty Stockfeeds, Yanderra, New South Wales, Australia) and
acidified tap water ad lib. The room temperature was 251C, and
ambient lighting was provided using GEC F40 GO fluorescent tubes
(GEC, Hobart, Tasmania, Australia) that do not emit UV radiation.
The dorsal fur was removed from the haired mice with electric
clippers (Oster clippers, no. 42 fine blade; Oster Manufacturing,
Milwaukee, WI) 24 hours before UV radiation exposure or topical
application of compounds. All procedures were approved by the
University of Sydney Animal Ethics Committee and complied with
the current New South Wales Animal Welfare Act.
UV radiation
Solar-simulated UV radiation was provided by a fluorescent tube
source comprising a bank of 6 120 cm UVA tubes (Hitachi 40W
F40T 10/BL, Tokyo, Japan) flanking a single 120 cm UVB tube
(Philips TL40W 12/RS, Eindhoven, The Netherlands) held in a
reflective batten and filtered through a 0.125mm sheet of cellulose
acetate (Grafix Plastics, Cleveland, OH) to remove wavelengths
below 290nm. The UVB (290–320nm) and UVA (320–400 nm)
components of this source were isolated by removing unwanted
tubes. UVB was filtered through cellulose acetate and UVA was
filtered through a 6mm window glass filter that is opaque to
wavelengths below 320nm. The fluorescent tubes also emit
substantial visible light; however, we have discounted a role for
visible light in the immune responses of the mouse by the lack of
effect of exposure through a 5mm Perspex (polymethyl methacry-
late) filter found to be opaque to UVB and transmitting less than
0.5% UVA radiation (unpublished observations).
Irradiance was measured using an International Light (New-
buryport, MA) IL1500 radiometer, with UVA and UVB detectors
calibrated to the relevant emission spectra (Table 1). Groups of mice
were irradiated with timed exposures on the dorsum, unrestrained in
their boxes with the wire lids removed. The temperature under the
lights was stabilized by an electric fan. The MEdD of SSUV in the
Skh:hr-1 hairless mouse has been previously established as being
1.33 kJ/m2 of UVB and 23.7 kJ/m2 of UVA (Reeve et al., 2006), and is
approximately twice this dose for normal Oster clipper-shaved
haired mice. Mice irradiated with UVA or UVB alone received a
single subedematous dose of 400 kJ/m2 UVA, which has been shown
to have optimal photoimmune protective properties (Allanson et al.,
2006), or 3.78 (hairless) or 7.56 (shaved haired) kJ/m2 UVB,
respectively, equivalent to approximately 3 MedD. When the two
wavebands were administered sequentially, the UVA exposure
immediately preceded the UVB exposure.
The SSUV irradiation was given as three daily consecutive
exposures of 1 MEdD. To increase the UVA content of the SSUV
source, the voltage supply only to the UVB tube was reduced using a
graduated transformer from 240 to 180V or 160V, while maintain-
ing a 240V supply to the UVA tubes, as previously described (Reeve
et al., 2006; Ibuki et al., 2007). This increased the UVA/UVB ratio
from 17.8 (SSUV) to 29.0 and 44.4, respectively, a model that
mimicks the prolonged sunlight exposure of humans while wearing
an UVB-absorbing topical sunscreen. The hair-shaved mice, there-
fore. received a constant daily UVB dose of 2.66 kJ/m2, with a UVA
dose of 47.7 (SSUV), 77.1, or 118.1 kJ/m2, respectively, on 3
consecutive days.
Induction of CHS
Contact hypersensitivity was induced in groups of five mice on days
8 and 9, following either single UV exposures or the first of 3
consecutive daily UV exposures, or topical compound applications,
by sensitizing the unirradiated abdominal skin (haired mice shaved
24 hours beforehand) with 0.1ml 2% oxazolone (Sigma Aldrich
Corp., Castle Hill, New South Wales, Australia) in ethanol, in order
to reveal systemic changes to immune responsiveness. Mice treated
only with the vehicle of the topical applications provided the ‘‘NIL’’
treatment-positive controls. All mice were challenged on day 15
with 5ml 2% oxazolone/ethanol applied to each surface of the
pinnae. The negative control treatment was ear challenge only (no
sensitization). Ear thickness was measured using a spring micrometer
before and repeatedly between 16 and 24hours after challenge, to
establish the peak ear swelling in the normal positive control mice.
The group average ear swelling at this time point and the %
suppression of the reaction by the UV or topical treatments were
calculated for each treatment group (Reeve, 2002). Statistical
significance of the differences between treatment groups was
obtained using Student’s t-test.
Immunohistochemical detection of IL-10 and HO-1
For IL-10 detection, groups of three shaved Er-b/ and normal
C57BL mice were exposed (or remained unexposed) to a single dose
Table 1. Spectral irradiance of the UV radiation
sources
UV source UVA (W/cm2) UVB (W/cm2) UVA/UVB ratio
SSUV 3.45 103 1.94104 17.8
UVA 2.7103 2.3 108 1.17 105
UVB 1.44 104 1.41104 1.02
SSUV, solar-simulated UV radiation.
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equivalent to 3 MEdD of SSUV or SSUV increasingly enriched for
UVA content. Five days after irradiation, the mice were killed and
mid-dorsal skin samples were fixed for 6 hours in Histochoice
(Amresco, Solon, OH), processed in an automated ethanol/formalin
system, wax embedded, and sections of 4mm were cut for
immunohistochemical staining. As described earlier in greater detail
(Shen et al., 1999; Reeve et al., 2006), IL-10 was identified by
incubation with a primary goat anti-mouse IL-10 antibody (R&D
Systems, Minneapolis, MN), followed by a secondary antibody
(horse HRP-conjugated anti-goat IgG(Hþ L), Vector Laboratories
Inc., Burlingame, CA), stained with the chromogen 3,30-diamino-
benzidine (DAB; Kirkegaard and Perry Laboratories Inc., Gaithers-
burg, MD), then counter-stained briefly with hematoxylin.
For HO-1 detection, groups of three shaved Er-b/ and normal
C57BL mice were exposed (or remained unexposed) to a single
dose of 400 kJ/m2 of UVA radiation. Frozen sections were cut (8 mm)
from mid-dorsal skin at 72 hours after irradiation when the
HO-1 protein expression is optimal (Allanson and Reeve, 2004),
and were briefly fixed in cold 4% paraformaldehyde in phosphate-
buffered saline. The staining procedure was as described earlier
(Allanson and Reeve, 2004), using a goat anti-mouse HO-1
polyclonal primary antibody (Santa Cruz Biotechnology, Santa Cruz,
CA) and a horse anti-goat HRP-conjugated secondary antibody
(Vector Laboratories), followed by DAB chromogen and hematoxylin
counterstaining.
The stained sections were examined for positive brown staining
under light microscopy, and images were captured digitally using a
Sony HyperHAD color video camera (Sony, Melbourne, Australia)
connected to a Leica Q500MC computer (Leica Microsystems,
Sydney, Australia). Semiquantitation of the positive area of the
epidermis was obtained using the Leica QWin version V01.00
(Cambridge, UK) for image analysis, averaged for 15 sequential
fields across the skin section from each of three mice per treatment
group, and analyzed statistically by Student’s t-test.
Treatment of mice with cis-urocanic acid
In some experiments, the mice were treated with a topical
application of the immunosuppressive mediator, cis-urocanic acid.
The cis isomer was produced by UVB irradiation of a thin layer of a
4% solution of trans-urocanic acid (Sigma Aldrich Corp.) in DMSO,
resulting in an equilibrium mixture of approximately 50% of each
isomer, referred to as ‘‘cis-urocanic acid’’ here, which was diluted
into a simple cosmetic oil-in-water emulsion to provide 0.2%
urocanic acids and 5% DMSO, as previously described (Allanson
and Reeve, 2005). Aliquots of 0.1ml (0.2mg urocanic acids) were
applied to the mouse dorsum on 3 consecutive days (combined with
three daily applications of CO-RM), or thrice within 24 hours
(combined with a single UVA exposure).
Treatment of mice with CO-RM or SnPP
The activity of HO was mimicked by treatment with its active
enzyme product, gaseous CO, or inhibited by treatment with its
substrate antagonist, SnPP. The compound, tricarbonyldichloror-
uthenium (II) dimer ([Ru(CO)3Cl2]2; Sigma Aldrich Corp.), known as
a ‘‘CO-RM,’’ releases gaseous CO when in a DMSO solution
(Allanson and Reeve, 2005). The CO-RM was freshly solubilized at
0.5mM in a 10% DMSO/lotion vehicle, and 0.2ml aliquots were
immediately applied to the mouse dorsum daily for days 1–3. The
control treatment was carried out with 0.2ml of the 10% DMSO/
lotion vehicle only. When combined with cis-urocanic acid
treatments, the CO-RM application preceded the cis-urocanic acid
by 1 hour.
In contrast, HO activity was inhibited by the subcutaneous
injection of 20 mmol/kg body weight of SnPP (Porphyrin Products,
Logan, UT), diluted in phosphate-buffered saline, pH 7.2, into the
lower abdominal skin immediately after SSUV irradiation and again
24 hours later, as previously described (Reeve and Tyrrell, 1999).
The control treatment involved the injection of phosphate-buffered
saline alone.
Treatment of mice with estradiol or ICI 182,780
The natural Er ligand, 17-b-estradiol (Sigma Aldrich Corp.), was
applied topically twice weekly to the dorsal skin of hairless mice at
50 nmol/0.1ml ethanol. Pharmacological Er blockade was achieved
with a twice weekly topical application of the Er antagonist, ICI
182,780 (Tocris Bioscience, Ellisville, MO), at 50 nmol/0.1ml
acetone. Treatments of either agent began 1 week before SSUV
irradiation, and continued for the following week until the mice
were sensitized for CHS induction.
Reverse-transcriptase–PCR for HO-1 mRNA
Groups of three C57BL and three Er-b/ mice were irradiated with
400 kJ/m2 of UVA, and dorsal skin samples were taken before and at
3, 6, and 24 hours after irradiation. Primer design, RNA extraction,
and the reverse-transcriptase–PCR procedure for murine HO-1 were
as previously described (Allanson and Reeve, 2004). The PCR
products were resolved electrophoretically on a 1.2% agarose gel
containing ethidium bromide, together with b-actin as the house-
keeping gene, and were visualized and captured digitally under UV
light (Kodak DC120 Digital camera, Kodak Australia Pty. Ltd,
Cobura, Australia). The bands were semiquantitated before and at
3 hours after UVA irradiation using the Quantity One (BioRad
version 4.1.1, BioRad Laboratories, Gladesville, NSW, Australia)
program, and the relative HO-1 mRNA expression was expressed
when normalized for b-actin.
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